F2 Gene Thrombophilia due to thrombin defect Genetic Test
Test Name: F2 Gene Thrombophilia due to thrombin defect Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Vascular Diseases
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for F2 Gene Thrombophilia due to thrombin defect NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F2 Gene Thrombophilia due to thrombin defect NGS Genetic DNA Test gene F2
Test Details: F2 gene thrombophilia is a genetic condition that increases the risk of developing abnormal blood clots in veins. It is caused by a defect in the F2 gene, which provides instructions for making a protein called prothrombin. Prothrombin is a key component in the blood clotting process.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the context of F2 gene thrombophilia, NGS genetic testing can be used to identify specific mutations or variations in the F2 gene that may be associated with an increased risk of abnormal blood clotting. This type of genetic testing can help healthcare professionals diagnose F2 gene thrombophilia, assess the risk of developing blood clots, and guide treatment decisions. It can also be useful for identifying family members who may be at risk and providing them with appropriate management strategies.
It is important to note that genetic testing results should always be interpreted in the context of an individual’s medical history and other risk factors. A positive result does not necessarily mean that a person will develop blood clots, and a negative result does not guarantee that a person is not at risk. Genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results.
Test Name | F2 Gene Thrombophilia due to thrombin defect Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Vascular Diseases |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for F2 Gene Thrombophilia due to thrombin defect NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F2 Gene Thrombophilia due to thrombin defect NGS Genetic DNA Test gene F2 |
Test Details | F2 gene thrombophilia is a genetic condition that increases the risk of developing abnormal blood clots in veins. It is caused by a defect in the F2 gene, which provides instructions for making a protein called prothrombin. Prothrombin is a key component in the blood clotting process. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the context of F2 gene thrombophilia, NGS genetic testing can be used to identify specific mutations or variations in the F2 gene that may be associated with an increased risk of abnormal blood clotting. This type of genetic testing can help healthcare professionals diagnose F2 gene thrombophilia, assess the risk of developing blood clots, and guide treatment decisions. It can also be useful for identifying family members who may be at risk and providing them with appropriate management strategies. It is important to note that genetic testing results should always be interpreted in the context of an individual’s medical history and other risk factors. A positive result does not necessarily mean that a person will develop blood clots, and a negative result does not guarantee that a person is not at risk. Genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results. |